my account
Login
  Loading... Please wait...

JAK

Sort by
  • AG-490 | 133550-30-8 | Structure | Supplier
    $50.00
    AG-490 (133550-30-8) is a potent inhibitor of the JAK-2 tyrosine kinase. In acute lymphoblastic leukemia (ALL) cells, which abundantly express JAK-2, AG-490 dose-dependently blocked cell growth, induced apoptosis and...

  • Lestaurtinib | FLT3/TrkA inhibitor
    $60.00
    Lestaurtinib (111358-88-4) is a potent and selective FLT3 inhibitor (IC50= 2 nM).1,2 Inhibits RET and RET phosphorylation in medullary thyroid carcinoma cells.3 Suppresses JAK2/STAT5 signaling and the proliferation of...

  • NSC-33994 | JAK2 inhibitor
    $85.00
    NSC-33994 (82058-16-0) is a remarkably potent and selective JAK2 inhibitor (IC50 = 60 nM). Displays no effect on Src and TYK2 tyrosine kinase activity at a concentration of 25 μM1. Suppresses JAK2-V617F-mediated human...

  • Ruxolitinib | JAK inhibitor
    $90.00
    Ruxolitinib (941678-49-5) is an ATP-competitive inhibitor of Janus-associated kinase 1 and 2. (IC50's of 2.7, 4.5 and 322 nm for JAK1, JAK2 and JAK3 respectively).1,2 Clinically useful cancer chemotherapeutic...

  • Tofacitinib | JAK inhibitor
    $95.00
    Tofacitinib (477600-75-2) is a JAK3 inhibitor, currently in clinical use. References/Citations1) Beavo et al. (1970), Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase...

  • WHI-P131 | 202475-60-3 | Structure | Supplier
    $50.00
    WHI-P131 (202475-60-3) is a JAK3 inhibitor. Inhibits human glioblastoma cell adhesion and invasion1. Increases survival in a mouse ALS model2. References/Citations1) Narla et al. (1998), Inhibition of human glioblastoma...

Share Focus

Connect with Focus